Trial Profile
Risk of Emergency Department or Inpatient Readmission Among Asthma Patients With An Initial Event
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors GSK
- 07 Apr 2011 New trial record